144 related articles for article (PubMed ID: 38928193)
21. Inflammatory and neurotrophic factor plasma levels are related to epilepsy independently of etiology.
Alvim MKM; Morita-Sherman ME; Yasuda CL; Rocha NP; Vieira ÉL; Pimentel-Silva LR; Henrique Nogueira M; Barbosa R; Watanabe N; Coan AC; Lopes-Cendes I; Teixeira AL; Cendes F
Epilepsia; 2021 Oct; 62(10):2385-2394. PubMed ID: 34331458
[TBL] [Abstract][Full Text] [Related]
22. Association analysis of high-mobility group box-1 protein 1 (HMGB1)/toll-like receptor (TLR) 4 with nasal interleukins in allergic rhinitis patients.
Zhu X; Cong J; Yang B; Sun Y
Cytokine; 2020 Feb; 126():154880. PubMed ID: 31739216
[TBL] [Abstract][Full Text] [Related]
23. High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
Han SY; Choi SH; Shin JS; Lee EJ; Han SH; Yoon JS
Thyroid; 2019 Jun; 29(6):868-878. PubMed ID: 30973094
[No Abstract] [Full Text] [Related]
24. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis.
Halstead S; Siskind D; Amft M; Wagner E; Yakimov V; Shih-Jung Liu Z; Walder K; Warren N
Lancet Psychiatry; 2023 Apr; 10(4):260-271. PubMed ID: 36863384
[TBL] [Abstract][Full Text] [Related]
25. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
26. n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis.
Frigerio F; Pasqualini G; Craparotta I; Marchini S; van Vliet EA; Foerch P; Vandenplas C; Leclercq K; Aronica E; Porcu L; Pistorius K; Colas RA; Hansen TV; Perretti M; Kaminski RM; Dalli J; Vezzani A
Brain; 2018 Nov; 141(11):3130-3143. PubMed ID: 30307467
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1.
Maroso M; Balosso S; Ravizza T; Liu J; Bianchi ME; Vezzani A
J Intern Med; 2011 Oct; 270(4):319-26. PubMed ID: 21793950
[TBL] [Abstract][Full Text] [Related]
28. Brain region and epilepsy-associated differences in inflammatory mediator levels in medically refractory mesial temporal lobe epilepsy.
Strauss KI; Elisevich KV
J Neuroinflammation; 2016 Oct; 13(1):270. PubMed ID: 27737716
[TBL] [Abstract][Full Text] [Related]
29. Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.
Dey A; Kang X; Qiu J; Du Y; Jiang J
Trends Pharmacol Sci; 2016 Jun; 37(6):463-484. PubMed ID: 27062228
[TBL] [Abstract][Full Text] [Related]
30. Neuroinflammation: A Common Pathway in Alzheimer's Disease and Epilepsy.
Liew Y; Retinasamy T; Arulsamy A; Ali I; Jones NC; O'Brien TJ; Shaikh MF
J Alzheimers Dis; 2023; 94(s1):S253-S265. PubMed ID: 37092226
[TBL] [Abstract][Full Text] [Related]
31. Multiple Disruptions of Glial-Neuronal Networks in Epileptogenesis That Follows Prolonged Febrile Seizures.
Brennan GP; Garcia-Curran MM; Patterson KP; Luo R; Baram TZ
Front Neurol; 2021; 12():615802. PubMed ID: 33679583
[No Abstract] [Full Text] [Related]
32. Role of Innate Immune Receptor TLR4 and its endogenous ligands in epileptogenesis.
Paudel YN; Angelopoulou E; Akyuz E; Piperi C; Othman I; Shaikh MF
Pharmacol Res; 2020 Oct; 160():105172. PubMed ID: 32871246
[TBL] [Abstract][Full Text] [Related]
33. HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction.
Paudel YN; Shaikh MF; Chakraborti A; Kumari Y; Aledo-Serrano Á; Aleksovska K; Alvim MKM; Othman I
Front Neurosci; 2018; 12():628. PubMed ID: 30271319
[TBL] [Abstract][Full Text] [Related]
34. Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures.
Choi J; Min HJ; Shin JS
J Neuroinflammation; 2011 Oct; 8():135. PubMed ID: 21989210
[TBL] [Abstract][Full Text] [Related]
35. Prospective clinical trials to investigate clinical and molecular biomarkers.
Auvin S; Walker L; Gallentine W; Jozwiak S; Tombini M; Sills GJ
Epilepsia; 2017 Jul; 58 Suppl 3():20-26. PubMed ID: 28675556
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms.
Alyu F; Dikmen M
Acta Neuropsychiatr; 2017 Feb; 29(1):1-16. PubMed ID: 27692004
[TBL] [Abstract][Full Text] [Related]
37. The effect of HMGB1 on sub-toxic chlorpyrifos exposure-induced neuroinflammation in amygdala of neonatal rats.
Tian J; Dai H; Deng Y; Zhang J; Li Y; Zhou J; Zhao M; Zhao M; Zhang C; Zhang Y; Wang P; Bing G; Zhao L
Toxicology; 2015 Dec; 338():95-103. PubMed ID: 26524701
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy.
Zhao J; Wang Y; Xu C; Liu K; Wang Y; Chen L; Wu X; Gao F; Guo Y; Zhu J; Wang S; Nishibori M; Chen Z
Brain Behav Immun; 2017 Aug; 64():308-319. PubMed ID: 28167116
[TBL] [Abstract][Full Text] [Related]
39. Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies.
van Vliet EA; Aronica E; Vezzani A; Ravizza T
Neuropathol Appl Neurobiol; 2018 Feb; 44(1):91-111. PubMed ID: 28977690
[TBL] [Abstract][Full Text] [Related]
40. The Potential Role of Pro-Inflammatory and Anti-Inflammatory Cytokines in Epilepsy Pathogenesis.
Kamali AN; Zian Z; Bautista JM; Hamedifar H; Hossein-Khannazer N; Hosseinzadeh R; Yazdani R; Azizi G
Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1760-1774. PubMed ID: 33200702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
